Clinical Trials · NCT07015268
A Clinical Study of KLH-2109 in Patients With Endometriosis
- Phase
- Phase 3
- Recruitment status
- Active Not Recruiting
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Enrollment
- 288
- Start date
- Jun 2025
- Locations
- 1 site, Japan
- Primary endpoint
- Change from baseline in the maximum NRS score for pelvic pain during 28 days prior to 12 weeks of the investigational product treatment